ABC | Volume 111, Nº2, Agosto 2018

Minieditorial Arq Bras Cardiol. 2018; 111(2):142-143 Fonseca Inflamação persistente após stent 1. Farsky PS, Hirata MH, Arnoni RT, Almeida AFS, Issa M, Lima PHO. Persistent Inflammatory Activity in Blood Cells and Artery Tissue from Patients with Previous Bare Metal Stent. Arq Bras Cardiol. 2018; 111(2):134-141 2. Caixeta AM, Brito FS Jr, Costa MA, Serrano CV Jr, Petriz JL, Da Luz PL. Enhanced inflammatory response to coronary stenting marks the development of clinically relevant restenosis. Catheter Cardiovasc Interv 2007;69(4):500-7. 3. The Interleukin-6 Receptor Mendelian Randomisation Analysis(IL6RMR) Consortium; Swerdlow DI, Holmes MV, Kuchenbaecker KB, Engmann JE, Shah T, Sofat R, et al. Lancet. 2012;379(9822) 1214-24. 4. Sarwar N, Butterworth AS, Freitag DF, Gregson J,Willeit P, GormanDN, et al. Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet. 2012;379(9822):1205-13. 5. RaoVH,RaiV,StoupaS,SubramanianS,AgrawalDK.Tumornecrosisfactor- α regulates triggering receptor expressed onmyeloid cells-1-dependent matrix metalloproteinases inthecarotidplaquesofsymptomaticpatientswithcarotid stenosis. Atherosclerosis. 2016May;248:160-9. 6. Ridker PM, Lüscher TF. Anti-inflammatory therapies for cardiovascular disease. Eur Heart J. 2014;35(27):1782-91. 7. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119-31. Referências Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 143